How Do You Manage Familial High Cholesterol on TRT? (TRT Q&As)
Timeline
A 43-year-old physician and Army veteran with a strong family history of early coronary disease asks how to protect his cardiovascular health while using testosterone. Dr. O’Connor emphasizes aggressive LDL control, coronary risk assessment, the ABCDs™, appropriate lipid-lowering therapy, and close monitoring while continuing medically necessary TRT.
Dr. O’Connor advises against donating blood simply to influence upcoming laboratory results. He explains that testosterone can cause androgen-induced erythrocytosis and emphasizes following the CBC together with iron studies, while using phlebotomy only when clinically appropriate rather than automatically donating around testing.
A 60-year-old man on long-term testosterone describes elevated hematocrit, low iron, and a low MCV after undergoing frequent phlebotomy. Dr. O’Connor explains that repeated blood removal can deplete iron stores and produce microcytosis even before overt anemia develops, so CBC and complete iron studies need to be interpreted together.
Dr. O’Connor advises against simply replacing the iron while continuing the same cycle of testosterone-driven erythrocytosis and frequent blood removal. He recommends addressing the underlying contributors, reducing unnecessary phlebotomy, monitoring CBC and iron studies together, and considering factors such as testosterone exposure, weight, and sleep apnea.
A 60-year-old member presents his first echocardiogram after a substantial steroid cycle and asks the group to review the findings. Dr. O’Connor focuses on left ventricular hypertrophy and a reported dilated aortic measurement, emphasizing cardiovascular risk reduction, blood pressure control, avoiding further steroid exposure, and obtaining appropriate specialist follow-up and more definitive imaging.
The member reviews a cycle that eventually exceeded 2.5 grams of total androgens per week, including Anavar and a rapid increase in Trenbolone. Dr. O’Connor emphasizes that this was substantial exposure and discusses concerns about cardiomyopathy, left ventricular hypertrophy, aortic dilation, cholesterol, and the importance of remaining off high-dose steroids while monitoring cardiovascular health.
Video Summary
The video features a live question-and-answer format where common health and hormone-related concerns are addressed in real time. It emphasizes patient education through practical explanations rather than technical detail. Topics span cardiovascular risk, hormone therapy considerations, and interpretation of laboratory results. The discussion reflects recurring questions seen in clinical practice. Emphasis is placed on individualized decision-making rather than blanket recommendations. The overall tone is educational and clarifying.
Several questions focus on how laboratory values should be interpreted in context rather than in isolation. The video explains why trends over time provide more meaningful insight than single data points. Common misconceptions around normal ranges and outliers are addressed. The importance of correlating symptoms with objective data is reinforced. Guidance is framed to reduce unnecessary anxiety around lab results. Clinical judgment is highlighted throughout.
Preventive strategies and follow-up considerations are also discussed. The video references lifestyle, monitoring, and appropriate use of medical therapy as part of long-term planning. Communication between patients and clinicians is encouraged to refine care decisions. Viewers are reminded that online information should supplement, not replace, professional guidance. Ongoing reassessment is presented as essential to good outcomes. The key message is informed engagement.
Drug Callouts
Condition Callouts
Key Takeaways
- Context matters in lab interpretation.
- Trends provide better insight than single values.
- Hormone decisions should be individualized.
- Prevention requires ongoing assessment.
- Engaged patients achieve better outcomes.